U.S. flag An official website of the United States government
  1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Human Drug Advisory Committees
  5. Pharmaceutical Science and Clinical Pharmacology Advisory Committee
  6. Pharmaceutical Science and Clinical Pharmacology Advisory Committee Roster
  1. Pharmaceutical Science and Clinical Pharmacology Advisory Committee

Pharmaceutical Science and Clinical Pharmacology Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info

Current Number of Vacancies = 4
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Chairperson (Pharmaceutical Science)
Kenneth R. Morris, MS, PhD
Expertise: Pharmaceutics
Term: 11/1/2018 – 10/31/2022
Director and Professor
Lachman Institute for Pharmaceutical Analysis
Long Island University, College of Pharmacy
75 Dekalb Avenue, L32
Brooklyn, New York 11201

Designated Federal Officer (Acting)
Yvette W. Waples, PharmD
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001 Fax: (301) 847-8533
E-mail: ACPS-CP@fda.hhs.gov

Chairperson (Clinical Pharmacology)

Paul M. Beringer, PharmD
Expertise: Clinical Pharmacology
Term: 11/1/2018 – 10/31/2022
Professor and Chair, Department of Clinical Pharmacy
University of Southern California, School of Pharmacy
1985 Zonal Avenue, B15E
Los Angeles, California 90089

Jeffery M. Carrico, PharmD, BCPS
Expertise: Clinical Research/Clinical Pharmacology/Human Subjects Protection
Term: 12/30/2015 – 10/31/2022
Service Chief, Clinical Pharmacy and Investigational Drug Research
Member, Institutional Review Board (IRB)
National Institutes of Health (NIH), Clinical Center
Bethesda, Maryland 20892

Jerry M. Collins, PhD
Expertise: Clinical Pharmacology and Drug Development/Regulation
Term: 11/1/2018 – 10/31/2022
Associate Director for Developmental Therapeutics
Division of Cancer Treatment and Diagnosis
National Cancer Institute, NIH
9609 Medical Center Drive, Room 4A632
Rockville, Maryland 20850

*Sandra Finestone, PsyD
Expertise: Consumer Representative
Term: 11/1/2017 – 10/31/2021
Executive Director
Association of Cancer Patient Educators
18025 Sky Park Circle, Suite A
Irvine, California 92614

Arthur H. Kibbe, PhD
Expertise: Excipients, Formulation and Pharmacokinetics
Term: 1/23/2020 – 10/31/2023
Emeritus Professor
Wilkes University, Nesbitt School of Pharmacy
84 West South Street
Wilkes-Barre, Pennsylvania 18766

Walter K. Kraft, MD, MS, FACP
Expertise: Clinical Pharmacology and Internal Medicine
Term: 11/1/2018 – 10/31/2022
Professor of Pharmacology and Experimental Therapeutics
Thomas Jefferson University
132 S. 10th Street, 1170 Main Building
Philadelphia, Pennsylvania 19107

Kelvin H. Lee, PhD
Expertise: Biopharmaceutical Development and Science
Term: 1/23/2020 – 10/31/2023
Gore Professor, Chemical & Biomolecular Engineering
University of Delaware
590 Avenue 1743
Newark, Delaware 19713

Frances J. Richmond, MSc, PhD
Expertise: Regulatory Science
Term: 9/27/2018 – 10/31/2021
Professor and Chair
Department of Regulatory and Quality Sciences
University of Southern California School of Pharmacy
1540 Alcazar Street
Los Angeles, California 90089

**Mark C. Rogge, PhD
Expertise: Translational Science, Biotechnology
Term: 11/1/2019 – 10/31/2023
Global Head & Vice President
Quantitative Translational Science
Takeda Pharmaceuticals International
40 Landsdowne Street
Cambridge, Massachusetts 02139

**Pravin Rothe, MPharm
Expertise: Validation and Technology Transfer
Term: 11/1/2019 – 10/31/2023
Validation Lead, Manufacturing Sciences and Technology
4700 Sandoz Drive
Wilson, North Carolina 27893

Eric V. Slud, PhD
Expertise: Mathematical Statistics
Term: 3/8/2019 – 10/31/2021
Area Chief for Mathematical Statistics
Center for Statistical Research and Methodology
Census Bureau
4600 Silver Hill Road
Washington, D.C. 20233

**T.G. Venkateshwaran, PhD
Expertise: Pharmaceutical Sciences
Term: 11/1/2019 – 10/31/2023
Associate Vice President and Global Head
Global Regulatory Affairs – CMC Biologics and Combination Products
Merck Research Laboratories, Ltd.
770 Sumneytown Pike
West Point, Pennsylvania 19486


* Consumer Representative
** Industry Representative (non voting)

Back to Top

Back to Top